PULSION Medical Systems SE Total Liabilities
PULSION Medical Systems SE total liabilities. Based on the latest financial reports, PULSION Medical Systems SE (PUS) has total liabilities worth €14.54 Million EUR (≈ $17.00 Million USD) as of December 2017. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check PULSION Medical Systems SE liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of PULSION Medical Systems SE (2000–2024)
Total liabilities of PULSION Medical Systems SE from 2000 to 2024. This chart illustrates how PULSION Medical Systems SE's total liabilities have evolved over time, based on quarterly financial data. Explore PULSION Medical Systems SE (PUS) long-term investment share to see how much of total assets are deployed in long-term investments.
PULSION Medical Systems SE Competitors by Total Liabilities
The table below lists competitors of PULSION Medical Systems SE ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Chia Ta World Co Ltd
TW:2033
|
Taiwan | NT$171.71 Million |
|
Kumpulan Fima Bhd
KLSE:6491
|
Malaysia | RM598.21 Million |
|
China Ecotek Corp
TW:1535
|
Taiwan | NT$3.44 Billion |
|
Hi-Clearance
TWO:1788
|
Taiwan | NT$2.03 Billion |
|
Namhae Chemical
KO:025860
|
Korea | ₩276.43 Billion |
|
Honma Golf Limited
F:HF5
|
Germany | €13.30 Billion |
|
Habco Trans Maritima
JK:HATM
|
Indonesia | Rp272.19 Billion |
|
Vitania Ltd
TA:VTNA
|
Israel | ILA2.09 Billion |
Liability Composition Analysis (2000–2024)
This chart breaks down PULSION Medical Systems SE's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see PUS total assets.
Liquidity & Leverage Metrics
PULSION Medical Systems SE Total Liabilities Ratios Explained
PULSION Medical Systems SE total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.71 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PULSION Medical Systems SE's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PULSION Medical Systems SE (2000–2024)
The table below shows the annual total liabilities of PULSION Medical Systems SE from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €18.78 Million ≈ $21.96 Million |
+44.55% |
| 2023-12-31 | €12.99 Million ≈ $15.19 Million |
+25.33% |
| 2022-12-31 | €10.37 Million ≈ $12.12 Million |
+17.57% |
| 2021-12-31 | €8.82 Million ≈ $10.31 Million |
-29.76% |
| 2020-12-31 | €12.55 Million ≈ $14.68 Million |
+32.93% |
| 2019-12-31 | €9.44 Million ≈ $11.04 Million |
-32.84% |
| 2018-12-31 | €14.06 Million ≈ $16.44 Million |
-3.31% |
| 2017-12-31 | €14.54 Million ≈ $17.00 Million |
+0.50% |
| 2016-12-31 | €14.47 Million ≈ $16.92 Million |
-68.07% |
| 2015-12-31 | €45.32 Million ≈ $52.98 Million |
+428.63% |
| 2013-12-31 | €8.57 Million ≈ $10.02 Million |
+2.51% |
| 2012-12-31 | €8.36 Million ≈ $9.78 Million |
-2.95% |
| 2011-12-31 | €8.62 Million ≈ $10.07 Million |
-6.07% |
| 2010-12-31 | €9.17 Million ≈ $10.73 Million |
+4.65% |
| 2009-12-31 | €8.77 Million ≈ $10.25 Million |
+15.21% |
| 2008-12-31 | €7.61 Million ≈ $8.90 Million |
-22.19% |
| 2007-12-31 | €9.78 Million ≈ $11.43 Million |
+20.64% |
| 2006-12-31 | €8.11 Million ≈ $9.48 Million |
-4.94% |
| 2005-12-31 | €8.53 Million ≈ $9.97 Million |
+3.15% |
| 2004-12-31 | €8.27 Million ≈ $9.66 Million |
+1.06% |
| 2003-12-31 | €8.18 Million ≈ $9.56 Million |
-32.40% |
| 2002-12-31 | €12.10 Million ≈ $14.15 Million |
+0.73% |
| 2001-12-31 | €12.01 Million ≈ $14.04 Million |
+2.32% |
| 2000-12-31 | €11.74 Million ≈ $13.73 Million |
-- |
About PULSION Medical Systems SE
PULSION Medical Systems SE engages in the development, production, and distribution of monitoring, diagnostic, and therapy control systems for recording physiological parameters of hospitalized, seriously ill, and intensive care patients. Its technologies include the PiCCO2 platform, a system used in intensive care medicine for the treatment of critically ill patients; PulsioFlex, which offers te… Read more